ES2079389T3 - Dispersiones de polimeros liofilizados y su uso para preparar composiciones farmaceuticas de liberacion retardada. - Google Patents

Dispersiones de polimeros liofilizados y su uso para preparar composiciones farmaceuticas de liberacion retardada.

Info

Publication number
ES2079389T3
ES2079389T3 ES90105437T ES90105437T ES2079389T3 ES 2079389 T3 ES2079389 T3 ES 2079389T3 ES 90105437 T ES90105437 T ES 90105437T ES 90105437 T ES90105437 T ES 90105437T ES 2079389 T3 ES2079389 T3 ES 2079389T3
Authority
ES
Spain
Prior art keywords
polymer dispersions
pharmaceutical compositions
lyophilized polymer
prepare delayed
delayed pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90105437T
Other languages
English (en)
Inventor
Dev K Mehra
Chimanal I Patel
Clayton I Bridges
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FMC Corp
Original Assignee
FMC Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FMC Corp filed Critical FMC Corp
Application granted granted Critical
Publication of ES2079389T3 publication Critical patent/ES2079389T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LATICES POLIMERICOS LIOFILIZADOS, QUE PUEDEN RECONSTITUIRSE EN AGUA PARA CONSEGUIR DISPERSIONES POLIMERICAS ACUOSAS CON UN ALTO CONTENIDO SOLIDO DE POLIMEROS. LAS DISPERSIONES POLIMERICAS RECONSTITUIDAS RESULTAN DE GRAN UTILIDAD EN LA PREPARACION DE FORMULACIONES FARMACEUTICAS DE DISTRIBUCION SOSTENIDA, EN PARTICULAR, DE FARMACOS SOLUBLES EN AGUA, MEDIANTE EL METODO DE GRANULACION HUMEDA SIN EXCESO DE HUMEDAD.
ES90105437T 1989-03-23 1990-03-22 Dispersiones de polimeros liofilizados y su uso para preparar composiciones farmaceuticas de liberacion retardada. Expired - Lifetime ES2079389T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32793489A 1989-03-23 1989-03-23

Publications (1)

Publication Number Publication Date
ES2079389T3 true ES2079389T3 (es) 1996-01-16

Family

ID=23278720

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90105437T Expired - Lifetime ES2079389T3 (es) 1989-03-23 1990-03-22 Dispersiones de polimeros liofilizados y su uso para preparar composiciones farmaceuticas de liberacion retardada.

Country Status (8)

Country Link
US (1) US5326572A (es)
EP (1) EP0388954B1 (es)
AT (1) ATE130511T1 (es)
CA (1) CA2012853A1 (es)
DE (1) DE69023682T2 (es)
DK (1) DK0388954T3 (es)
ES (1) ES2079389T3 (es)
GR (1) GR3018970T3 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5968551A (en) 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
SE9203594D0 (sv) * 1992-11-30 1992-11-30 Christer Nystroem Laekemedel i dispersa system
DE4244466C2 (de) * 1992-12-24 1995-02-23 Pharmatech Gmbh Verfahren zur Herstellung von Pseudolatices und Mikro- oder Nanopartikeln und deren Verwendung zur Herstellung von pharmazeutischen Präparaten
IL110014A (en) 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
DE4324474A1 (de) * 1993-07-21 1995-01-26 Henkel Kgaa Verwendung ausgewählter Polyvinylacetat-Dispersionen für die Oberflächenverfestigung von Sand und/oder Erdreich
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
DE4413350A1 (de) * 1994-04-18 1995-10-19 Basf Ag Retard-Matrixpellets und Verfahren zu ihrer Herstellung
DE4423078B4 (de) * 1994-07-01 2005-01-13 Awd.Pharma Gmbh & Co. Kg Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
US5684121A (en) * 1994-12-06 1997-11-04 Isp Investments Inc. N-vinyl lactam polymer containing tablets of low friability and high rate of dissolution
EP0797987B1 (en) * 1994-12-19 2003-10-15 Daiichi Pharmaceutical Co., Ltd. Sustained-release granular preparation and process for producing the same
US5985313A (en) * 1997-10-22 1999-11-16 New York Blood Center, Inc. Method for decreasing the frequency of transmission of viral infections using cellulose acetate phthalate or hydroxypropyl methylcellulose phthalate excipients
US6165493A (en) * 1997-10-22 2000-12-26 New York Blood Center, Inc. "Methods and compositions for decreasing the frequency of HIV, herpesvirus and sexually transmitted bacterial infections"
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
KR20020059653A (ko) 1999-10-29 2002-07-13 그린 마틴, 브라이언 쥐 테슬리 서방성 하이드로코돈 제형
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
HU230686B1 (en) 2000-10-30 2017-08-28 Euro Celtique Sa Controlled release hydrocodone compositions
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
UA81224C2 (uk) 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
US20040115266A1 (en) * 2002-02-01 2004-06-17 Namburi Ranga Raju Oral itraconazole formulations and methods of making the same
US20040265378A1 (en) * 2003-06-25 2004-12-30 Yingxu Peng Method and compositions for producing granules containing high concentrations of biologically active substances
WO2007092718A2 (en) * 2006-02-07 2007-08-16 Fmc Corporation Coating process to produce controlled release coatings
US20070281016A1 (en) * 2006-06-06 2007-12-06 Endo Pharmaceuticals Inc., A Delaware Corporation Sustained release oxycodone composition with acrylic polymer and surfactant
US20080020032A1 (en) * 2006-07-21 2008-01-24 Michael Crowley Hydrophobic abuse deterrent delivery system for hydromorphone
US20080200890A1 (en) * 2006-12-11 2008-08-21 3M Innovative Properties Company Antimicrobial disposable absorbent articles
US9555167B2 (en) * 2006-12-11 2017-01-31 3M Innovative Properties Company Biocompatible antimicrobial compositions
KR20210053921A (ko) * 2018-08-31 2021-05-12 에보니크 오퍼레이션즈 게엠베하 중합체 분말을 제조하는 방법
CN114456404B (zh) * 2022-01-24 2024-02-13 哈尔滨工业大学 一种液态金属柔性可穿戴器件及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2800463A (en) * 1953-05-14 1957-07-23 Shawinigan Resins Corp Polyvinyl acetate powder and process of making the same
US2809192A (en) * 1954-05-25 1957-10-08 Atlantic Res Corp Method of making cellulose esters in the form of small, dense, spherical particles
US3942261A (en) * 1973-12-21 1976-03-09 Toyo Ink Manufacturing Co., Ltd. Method for producing powder paint
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
AU569277B2 (en) * 1983-03-03 1988-01-28 Dow Chemical Company, The Aqueuos dispersion of water-insoluble organophilic cellulose ether for sustained release of active agents
US4652442A (en) * 1983-07-05 1987-03-24 Arcana Chem. Pharm. Fabrik Gesellschaft M.B.H. Process of producing a sustained release preparation containing indomethacin or niomethacin
DE3877678T2 (de) * 1987-04-16 1993-10-07 Christian Bindschaedler Verfahren zur herstellung eines wasserunlöslichen polymerpulvers, das in einer flüssigen phase redispergiert werden kann und verfahren zur herstellung einer dispersion des polymerpulvers.
US4960814A (en) * 1988-06-13 1990-10-02 Eastman Kodak Company Water-dispersible polymeric compositions

Also Published As

Publication number Publication date
CA2012853A1 (en) 1990-09-23
EP0388954A3 (en) 1992-09-09
EP0388954A2 (en) 1990-09-26
DE69023682T2 (de) 1996-04-18
GR3018970T3 (en) 1996-05-31
EP0388954B1 (en) 1995-11-22
DK0388954T3 (da) 1995-12-18
DE69023682D1 (de) 1996-01-04
ATE130511T1 (de) 1995-12-15
US5326572A (en) 1994-07-05

Similar Documents

Publication Publication Date Title
ES2079389T3 (es) Dispersiones de polimeros liofilizados y su uso para preparar composiciones farmaceuticas de liberacion retardada.
DK74187A (da) Praeparat til langsom frigivelse samt fremgangsmaade til fremstilling deraf
CA2027592A1 (en) Solid pharmaceutical preparations of active form of vitamin d_ of improved stability
DK0642301T3 (da) Farmaceutisk acceptable fikserede, tørrede humane blodplader
ES2061799T3 (es) Nuevo preparado medicamentoso y procedimiento para su preparacion.
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
ATE197808T1 (de) In wässriger lösung redispergierbare polymerpulver
EE9400356A (et) Polüetüleenglükool proteiin konjugaadid, ühendid, nende kasutamine, meetod konjugaatide valmistamiseks ja ravimvormid
PT83750B (pt) Processo para a preparacao de composicoes farmaceuticas de ibuprofen
ATE154822T1 (de) Präparate von fettlöslichen substanzen
DE69033874T2 (de) Verfahren zur Herstellung von arzneimittelenthaltenden gefriergetrockneten Formulierungen
ATE319329T1 (de) Stabile pulverförmige vitamin-und/oder carotinoid-präparate und verfahren zu deren herstellung
ES2011232A4 (es) Compuestos farmaceuticos en piroxicam en soluciones acuosas y proceso para su preparacion
RU2003102367A (ru) Эндопаразитоцидные средства для добровольного орального приема внутрь животными
HUP9902165A2 (hu) Nagy fajlagos felületű D-mannit, eljárás előállítására, valamint ilyen mannitot tartalmazó szilárd kompozíciók
GB2334446B (en) Aqueous compositions compromising a lipid and a lanolin-derived surfactant,and their use
ES2111149T3 (es) Extracto a base de proteinas bacterianas, procedimiento para su preparacion y composicion farmaceutica que lo contiene.
FR2613223B1 (fr) Forme galenique se presentant sous la forme de grains hydrosolubles, en particulier a base d'un extrait sec de ginkgo biloba, et son procede de preparation
DE59001005D1 (de) Hilfsmittelfreie riboflavingranulate.
ES499363A0 (es) Procedimiento para la obtencion de derivados de fenilpipera-cina de 1,3,4-oxadiazolilfenoles
ES2038587T3 (es) Procedimiento para el secado y granulado simultaneo de extractos de sangre desalbuminada de ternero, granulado obtenido segun este procedimiento y su utilizacion para la fabricacion de preparados farmaceuticos.
ES2084747T3 (es) Polimeros en emulsion liberados de emulsionantes en preparados farmaceuticos con liberacion retardada de la sustancia activa, y su preparacion.
ES2060440T3 (es) Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos.
ES2054530T3 (es) Procedimiento para la preparacion de formulacion de espiramicina y formulacion oral de espiramicina.
RU96106117A (ru) Способ получения живой коревой вакцины

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 388954

Country of ref document: ES